Electrochemical POC device for fast malaria quantitative diagnosis in whole blood by using magnetic beads, Poly-HRP and microfluidic paper electrodes.


Journal

Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289

Informations de publication

Date de publication:
15 Feb 2020
Historique:
received: 27 09 2019
revised: 16 11 2019
accepted: 25 11 2019
pubmed: 11 12 2019
medline: 24 11 2020
entrez: 11 12 2019
Statut: ppublish

Résumé

Malaria, a parasitic infection caused by Plasmodium parasites and transmitted through the bite of infected female Anopheles mosquitos, is one of the main causes of mortality in many developing countries. Over 200 million new infections and nearly half a million deaths are reported each year, and more than three billion people are at risk of acquiring malaria worldwide. Nevertheless, most malaria cases could be cured if detected early. Malaria eradication is a top priority of the World Health Organisation. However, achieving this goal will require mass population screening and treatment, which will be hard to accomplish with current diagnostic tools. We report an electrochemical point-of-care device for the fast, simple and quantitative detection of Plasmodiumfalciparum lactate dehydrogenase (PfLDH) in whole blood samples. Sample analysis includes 5-min lysis to release intracellular parasites, and stirring for 5 more min with immuno-modified magnetic beads (MB) along with an immuno-modified signal amplifier. The rest of the magneto-immunoassay, including sample filtration, MB washing and electrochemical detection, is performed at a disposable paper electrode microfluidic device. The sensor provides PfLDH quantitation down to 2.47 ng mL

Identifiants

pubmed: 31818756
pii: S0956-5663(19)31004-8
doi: 10.1016/j.bios.2019.111925
pii:
doi:

Substances chimiques

Immunoconjugates 0
L-Lactate Dehydrogenase EC 1.1.1.27

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111925

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Gisela Ruiz-Vega (G)

Diagnostic Nanotools Group, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

Kevin Arias-Alpízar (K)

Diagnostic Nanotools Group, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

Erica de la Serna (E)

Diagnostic Nanotools Group, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

Livia Neves Borgheti-Cardoso (LN)

Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain.

Elena Sulleiro (E)

Microbiology Department, Vall d'Hebron University Hospital (VHUH), UAB, Barcelona, Spain; PROSICS (Catalan International Health Program), Barcelona, Spain.

Israel Molina (I)

PROSICS (Catalan International Health Program), Barcelona, Spain; Infectious Diseases Department, VHUH, UAB, PROSICS (Catalan International Health Program), Barcelona, Spain.

Xavier Fernàndez-Busquets (X)

Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain; Nanoscience and Nanotechnology Institute (IN2UB), Barcelona, Spain.

Adrián Sánchez-Montalvá (A)

PROSICS (Catalan International Health Program), Barcelona, Spain; Infectious Diseases Department, VHUH, UAB, PROSICS (Catalan International Health Program), Barcelona, Spain.

F Javier Del Campo (FJ)

Centro Nacional de Microelectrónica (IMB-CNM, CSIC), Barcelona, Spain.

Eva Baldrich (E)

Diagnostic Nanotools Group, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Spain. Electronic address: eva.baldrich@vhir.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH